These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1551868)

  • 1. Cloning and characterization of cDNA encoding canine alpha-L-iduronidase. mRNA deficiency in mucopolysaccharidosis I dog.
    Stoltzfus LJ; Sosa-Pineda B; Moskowitz SM; Menon KP; Dlott B; Hooper L; Teplow DB; Shull RM; Neufeld EF
    J Biol Chem; 1992 Apr; 267(10):6570-5. PubMed ID: 1551868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human alpha-N-acetylgalactosaminidase-molecular cloning, nucleotide sequence, and expression of a full-length cDNA. Homology with human alpha-galactosidase A suggests evolution from a common ancestral gene.
    Wang AM; Bishop DF; Desnick RJ
    J Biol Chem; 1990 Dec; 265(35):21859-66. PubMed ID: 2174888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of -3c-g acceptor splice site mutation in human alpha-L-iduronidase associated with mucopolysaccharidosis type IH/S.
    Teng YN; Wang TR; Hwu WL; Lin SP; Lee-Chen GJ
    Clin Genet; 2000 Feb; 57(2):131-6. PubMed ID: 10735634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of the molecular lesion causing mucopolysaccharidosis type I in cats.
    He X; Li CM; Simonaro CM; Wan Q; Haskins ME; Desnick RJ; Schuchman EH
    Mol Genet Metab; 1999 Jun; 67(2):106-12. PubMed ID: 10356309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human alpha-L-iduronidase: cDNA isolation and expression.
    Scott HS; Anson DS; Orsborn AM; Nelson PV; Clements PR; Morris CP; Hopwood JJ
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9695-9. PubMed ID: 1946389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myoblast gene therapy in canine mucopolysaccharidosis. I: Abrogation by an immune response to alpha-L-iduronidase.
    Shull RM; Lu X; McEntee MF; Bright RM; Pepper KA; Kohn DB
    Hum Gene Ther; 1996 Aug; 7(13):1595-603. PubMed ID: 8864760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucopolysaccharidosis type I: characterization of novel mutations affecting alpha-L-iduronidase activity.
    Lee-Chen GJ; Lin SP; Tang YF; Chin YW
    Clin Genet; 1999 Jul; 56(1):66-70. PubMed ID: 10466419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Architecture of the canine IDUA gene and mutation underlying canine mucopolysaccharidosis I.
    Menon KP; Tieu PT; Neufeld EF
    Genomics; 1992 Nov; 14(3):763-8. PubMed ID: 1339393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine alpha-L-iduronidase: cDNA isolation and expression.
    Clarke LA; Nasir J; Zhang H; McDonald H; Applegarth DA; Hayden MR; Toone J
    Genomics; 1994 Nov; 24(2):311-6. PubMed ID: 7698753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel p.E276K IDUA mutation decreasing α-L-iduronidase activity causes mucopolysaccharidosis type I.
    Prommajan K; Ausavarat S; Srichomthong C; Puangsricharern V; Suphapeetiporn K; Shotelersuk V
    Mol Vis; 2011 Feb; 17():456-60. PubMed ID: 21364962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
    Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ
    Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucopolysaccharidosis type I: Identification and characterization of mutations affecting alpha-L-iduronidase activity.
    Lee-Chen GJ; Lin SP; Chen IS; Chang JH; Yang CW; Chin YW
    J Formos Med Assoc; 2002 Jun; 101(6):425-8. PubMed ID: 12189649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients.
    Hein LK; Bawden M; Muller VJ; Sillence D; Hopwood JJ; Brooks DA
    J Mol Biol; 2004 Apr; 338(3):453-62. PubMed ID: 15081804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosidase active site mutations in human alpha-L-iduronidase.
    Brooks DA; Fabrega S; Hein LK; Parkinson EJ; Durand P; Yogalingam G; Matte U; Giugliani R; Dasvarma A; Eslahpazire J; Henrissat B; Mornon JP; Hopwood JJ; Lehn P
    Glycobiology; 2001 Sep; 11(9):741-50. PubMed ID: 11555618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In utero injection of alpha-L-iduronidase-carrying retrovirus in canine mucopolysaccharidosis type I: infection of multiple tissues and neonatal gene expression.
    Meertens L; Zhao Y; Rosic-Kablar S; Li L; Chan K; Dobson H; Gartley C; Lutzko C; Hopwood J; Kohn D; Kruth S; Hough MR; Dubé ID
    Hum Gene Ther; 2002 Oct; 13(15):1809-20. PubMed ID: 12396614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of gentamicin inducing readthrough premature stop Codons: A study of alpha-L-iduronidase nonsense variants in COS-7 Cells.
    Ngiwsara L; Sawangareetrakul P; Wattanasirichaigoon D; Tim-Aroon T; Dejkhamron P; Champattanachai V; Ketudat-Cairns JR; Svasti J
    Biochem Biophys Res Commun; 2022 Dec; 636(Pt 1):147-154. PubMed ID: 36332477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The alpha-L-iduronidase mutations R89Q and R89W result in an attenuated mucopolysaccharidosis type I clinical presentation.
    Hein LK; Hopwood JJ; Clements PR; Brooks DA
    Biochim Biophys Acta; 2003 Oct; 1639(2):95-103. PubMed ID: 14559116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for canine alpha-L-iduronidase deficiency: in utero adoptive transfer of genetically corrected hematopoietic progenitors results in engraftment but not amelioration of disease.
    Lutzko C; Omori F; Abrams-Ogg AC; Shull R; Li L; Lau K; Ruedy C; Nanji S; Gartley C; Dobson H; Foster R; Kruth S; Dubé ID
    Hum Gene Ther; 1999 Jun; 10(9):1521-32. PubMed ID: 10395377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients.
    Matte U; Yogalingam G; Brooks D; Leistner S; Schwartz I; Lima L; Norato DY; Brum JM; Beesley C; Winchester B; Giugliani R; Hopwood JJ
    Mol Genet Metab; 2003 Jan; 78(1):37-43. PubMed ID: 12559846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c.1898C>G/p.Ser633Trp Mutation in Alpha-L-Iduronidase: Clinical and Structural Implications.
    Peña-Gomar I; Jiménez-Mariscal JL; Cerón M; Rosas-Trigueros J; Reyes-López CA
    Protein J; 2021 Feb; 40(1):68-77. PubMed ID: 33389473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.